György A. Marko‐varga - Nanotechnology

Author Information

György A. Marko-varga is a prominent researcher affiliated with Lund University in Lund, Sweden. His research work spans various domains in biomedical sciences and nanotechnology, with a particular focus on proteomics and biomarker discovery. His contributions have significantly advanced our understanding of complex biological systems and disease mechanisms.

Research Contributions

György A. Marko-varga has authored numerous influential papers, contributing to fields such as glioma research, proteomic alterations in polycystic ovary syndrome, and plasma metabolomics. His recent studies investigate novel protein markers of androgen activity, non-invasive sampling techniques for skin cancer biomarkers, and the implications of PMCA4 expression in melanoma. His diverse research output reflects a strong commitment to advancing diagnostic and therapeutic strategies in human health.

Aliases

György A. Marko-varga is known by several aliases in academic publications, including György Markó-varga, Gyorgy Marko-varga, and G. Marko-varga. These variations are a result of transliterations and formatting differences across different platforms and publications.

Publication and Citation Metrics

Metric	Value
Paper Count	500
Citation Count	12,321
H-index	54

Publications:

Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization

DOI: 10.1073/pnas.2114456119

Year: 2022

Proteomic Alterations in Follicular Fluid of Human Small Antral Follicles Collected from Polycystic Ovaries—A Pilot Study

DOI: 10.3390/life12030391

Year: 2022

Metabolic changes induced by pharmacological castration of young, healthy men: a study of the plasma metabolome

DOI: 10.1101/2022.03.08.22271577

Year: 2022

Non-Invasive, Topical Sampling of Potential, Low-Molecular Weight, Skin Cancer Biomarkers: A Study on Healthy Volunteers

DOI: 10.1021/acs.analchem.1c05470

Year: 2022

Method Matters: Exploring Alkoxysulfonate-Functionalized Poly(3,4-ethylenedioxythiophene) and Its Unintentional Self-Aggregating Copolymer toward Injectable Bioelectronics

DOI: 10.1021/acs.chemmater.1c04342

Year: 2022

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition

DOI: 10.3390/ijms23063324

Year: 2022

Novel protein markers of androgen activity in humans: proteomic study of plasma from young chemically castrated men

DOI: 10.7554/eLife.74638

Year: 2022

Erratum to: Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers.

DOI: 10.1093/ehjacc/zuab107

Year: 2021

RUBIC (ReproUnion Biobank and Infertility Cohort): A binational clinical foundation to study risk factors, life course, and treatment of infertility and infertility‐related morbidity

DOI: 10.1111/andr.13063

Year: 2021

Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasis

DOI: 10.1038/s41598-021-85162-0

Year: 2021

How Do These Agencies Function?

How is ITO Synthesized?

What Are the Benefits of Nanotechnology in Drug Release?

What ethical issues are associated with Nanotechnology?

How Do OECD Test Guidelines Impact Regulatory Policies?

What is Focused Ion Beam (FIB) Machining?

What are the Benefits of Using Fourier Transform in Nanotechnology?

Why is Protein Corona Formation Important?

What Are the Advantages of Nanotechnology in Dermatology?

What is the Future of Metal Nanoparticles in Nanotechnology?

Partnered Content Networks

Relevant Topics